| Logo | Name | Σ | Employees | ||
|---|---|---|---|---|---|
 |  Aurum Biosciences Ltd Imaging life, protecting lives. Aurum Biosciences Ltd is a clinical stage biopharmaceutical company developing novel oxygen carriers for use as therapeutics and diagnostics, initially for Acute Ischaemic Stroke (AIS). Follow-on indications include heart disease, oncology, inflammatory conditions, spinal cord injury, and dementia. Preclinical development has been completed in the lead indication (AIS) and approval has been granted to initiate clinical studies in acute stroke patients. Concurrently, Aurum is pursuing opportunities to develop its pipeline indications with a focus on inflammatory conditions and oncology. Type: | 0 | 0 | 0 | 5 |
 |  Mesenbio Using mesenchymal stem cells to produce therapeutically meaningful extracellular vesicles. We are a recently incorporated limited company, spun out from the University of York from the Genever lab (www.geneverlab.info), which has over 20 years of experience in cell biology and regenerative medicine. We focus on musculoskeletal regeneration using mesenchymal stem cells (MSCs), with a view to translate our body of work into cutting edge therapeutics. Our current focal point is the field of extracellular vesicles (EVs), which have recently gained substantial traction as a next-generation therapeutic modality. We believe that current approaches have room for improvement in terms of consistency … Type: | 2 | 0 | 2 | 9 |
 | GliaPharm SA Targeting Glial Cells and Brain Metabolism to Treat Neurological Diseases GliaPharm is a Swiss-based biotechnology company that develops treatments for neurological and psychiatric disorders. GliaPharm's innovative therapeutic approach is to target glial cells, the 'support cells' of neurons, to sustain and enhance brain metabolism in pathological conditions. Our vision is to become a leading biotechnology company with a focus on glia-mediated pathways as agents for neuroprotection and maintenance of cognitive functions. Type: | 1 | 1 | 0 | 12 |
 | Corporis Medical Corporis Medical focuses on the development and commercialization of innovative surgical devices. Corporis Medical is a start-up company that focusses on the development and commercialization of innovative medical devices that improve outcomes of surgical interventions. Our founder is dr. Alexander Veenhof, surgeon at the NKI-AvL who specializes in oncologic surgery in the thorax, esophagus, stomach and adrenal gland. His experiences in the operating room are the inspiration for the devices we develop. We are currently working on bringing two devices to the market: LaprixaTM and MedicloseTM. LaprixaTM is the world’s smallest tissue blood pressure measuring device, which offers the surgeon … Type: | 0 | 0 | 0 | 15 |
 | Embla Leading the fight against obesity by helping people lose weight sustainably. The biggest lie in obesity care is that there are easy fixes. This is an industry addicted to over-simplification, misinformation and inauthentic stock photos. None of it is real. Weight loss is complicated because people are. It’s tied to genetics, personality, lifestyle, hormones, habits, relationships and psychology. Embla exists to challenge the world’s reductive approach to weight loss, to reduce the harm to people’s health and our health system. We do this by combining science, compassion and service excellence. Highly personalised weight loss care that works because it’s precisely … Type: | 3 | 0 | 2 | 56 |
 | Newrotex Ltd UK SME, exploiting the regenerative properties of silk for peripheral nerve repair Newrotex is an Oxford-based SME that has developed an off-the-shelf silk-based conduit for the repair of peripheral nerve injuries. Peripheral Nerve Injury, Silk, Medical Device, Regenerative Medicine, and Biotech Type: | 1 | 0 | 0 | 5 |
 | KYLYS BIOMOLECULES NOW, FOR YOUR FUTURE KYLYS is a Life Science Spin-off from the University of Geneva, now ready to step into clinical development. Passionate about science and biotechnology, we are committed to developing a unique technology to deliver highly effective and safe products based on the next generation of hyaluronic acid (HA). Our products are aesthetic (KYLYS Aesthetics) and medical (KYLYS). Our technology can revolutionize HA delivery for medical and surgical needs, in the field of: Aesthetic Rheumatology Reconstructive surgery Drug delivery system Veterinary Type: | 0 | 0 | 0 | 4 |
 | DEBx Medical Innovating the future of wound care DEBx Medical is a leading innovator in advanced wound care solutions, dedicated to transforming the landscape of wound healing. With a focus on removing infection and biofilm, DEBx Medical pioneers groundbreaking solutions to address the unique challenges of hard-to-heal wounds. Medical devices, Healthcare, Infection, Advanced Wound Care, Wound Care, and Biofilm Type: | 0 | 0 | 0 | 8 |
 | Seamless Therapeutics Seamless Therapeutics is overcoming the boundaries of gene editing by unlocking the full potential of recombinases. Seamless Therapeutics is changing the paradigm of gene editing through a pioneering approach to restore health in patients with severe conditions in a safe and precise manner. Our technology platform unlocks the reprogramming of recombinases, a highly versatile class of enzymes. We are applying our proprietary know-how to develop a pipeline of disease-modifying product candidates across a broad spectrum of indications to expand the therapeutic potential of gene editing. Type: | 1 | 1 | 0 | 28 |
 |  DP Innovations Ltd. Pulmonary drug delivery with near 100% efficiency DP Innovations Ltd is a privately held healthcare company based in Woodside, CA. The main activity of the company is the development of an innovative pulmonary drug delivery system called SPRIN. SPRIN provides pharmaceutical companies with an alternative delivery system to needle injection for high-precision drugs, such as insulin, gene therapy, antivirals, etc. Type: | 0 | 0 | 0 | 1 |
 | Diamante Società Benefit Srl Plant-based Nanotechnologies for autoimmune diseases diagnoses and therapy DIAMANTE (Nano-Technologies for Autoimmune Disease) is a biotech company focused on the use of plants for producing high value-added molecules. The company was funded in 2016 with the development of new tools in autoimmune disease diagnosis and now we are growing approaching therapeutics applications. As an innovation-oriented female company, our value proposition is the creation of novel therapeutic approach for autoimmune diseases based on the restoration of self-tolerance, using plant viruses displaying immunodominant peptides. Diamante, thanks to the Regione Veneto and particularly though the national grant POR FESR AZIONE 1.1.1 2020/2021, has … Type: | 0 | 0 | 0 | 16 |
 | RheoDx Cloud Based Haematology Diagnostics Delivered aaS RheoDx is a diagnostics company committed to improving the quality of life of hematology patients and the efficiency in their clinical management. Develops an inexpensive medical device that monitors red blood cells conditions in less than five minutes with a drop. Its small size and simplicity allow to be used at the point-of-care and at home. Spin-off of the Centre Recerca Matemàtica (CRM), and incorporated in the Collider, the venture builder of tech transfer by Mobile World Capital Foundation. Medical Devices, In vitro diagnostics, Hematology, Point-of-care, Transfusions, and Blood cells conditions Type: | 3 | 1 | 0 | 3 |
 | fisio360 [Automatic translation follows] At the fisio360 physiotherapy centres you will find specialised care exclusively from physiotherapists The fisio360 physiotherapy clinics offer you modern facilities with the latest technology and with qualified physiotherapists with extensive experience and ongoing training. The philosophy of our centre is to provide individualised and personalised treatment, since not all pathologies are the same and not all people have the same needs. physiotherapy, Therapeutic Massage, Osteopathy, and franchise Type: | 0 | 0 | 0 | 15 |
 | Enzymlogic Enzymlogic is a world leader in the kinetic profiling of compounds to facilitate drug discovery. Enzymlogic is a world leader in the kinetic profiling of compounds to facilitate drug discovery. As experts in the generation and interpretation of kinetic data, we pride ourselves on a proven track record of successful partnerships with worldwide organizations of all sizes, supporting them on a routine basis during the early phases of drug discovery. We use exquisitely tuned assays to deliver accurate, robust and reproducible kinetic data of the highest quality that enhances the identification of compounds with the greatest therapeutic potential. The insight … Type: | 4 | 2 | 2 | 10 |
 | SOM Biotech Biopharmaceutical company focused on the accelerated development of drugs for orphan indications through AI technology SOM Biotech is a biopharmaceutical company focused on the accelerated discovery and development of therapies for orphan indications through a proprietary artificial intelligence-based drug discovery technology and developing strategic partnerships with major research centers and pharmaceutical companies. SOM AI PRO Technology is a proprietary AI-based validated drug discovery technology of SOM Biotech. After defining drug candidates through the technology, we successfully finished the Clinical Phase 2a of two drugs with very positive results. This will contribute to treating two relevant neurodegenerative diseases more effectively, meeting … Type: | 4 | 2 | 3 | 15 |
 | BioExpert Network Revolutionise science with your knowledge The BioExpert Network, or BEN, is an exclusive network of experts in the sectors of health, biotechnology, life science and investment. Members have the opportunity to access and evaluate funding proposals for innovative research and development projects before anyone else, and help shape the future of life science and medicine. Proposals which receive the most positive evaluations, in terms of innovation, scientific validity, team and business potential have the opportunity to progress to a crowdfunding campaign with Capital Cell, the first online investment platform in Europe specialized in health and biotechnology. PhD level scientists, physicians, … Type: | 1 | 0 | 1 | 263 |
 | NOVAMEAT Plant-Based Meat, Reinvented Based in the vibrant city of Barcelona, Novameat provides a range of authentic and sustainable plant-based meats. We simplify conscious choices, empowering people to effortlessly prioritise personal well-being and the future of our planet, without compromising on the gastronomic experience. Led by passionate innovators, we blend expertise in food science, biotechnology, and culinary arts to craft a unique texturising technology, creating nutritious food with an original taste and texture, and a satisfying bite. No soy, no gluten, no complex additives. Only protein-packed goodness. plant-based meat, food tech, cell-cultured meat, microextrusion, food, vegan, alternativeproteins, plantbased, altproteins, wholecuts, foodmanufacturing, … Type: | 6 | 1 | 4 | 35 |
 | Nostrum Biodiscovery Rethink and Accelerate Nostrum Biodiscovery is a spin-off from the Barcelona Supercomputing Center (BSC-CNS) and the Institute for Research in Biomedicine (IRB), two of the most recognized Spanish international research centers. Nostrum Biodiscovery provide advanced technologies in Molecular Modelling, with two areas of focus : therapeutics, e.g. small molecules design, targeted protein degradation, antibodies, immunologics and nucleic acids, and bio-based chemistry as in enzyme engineering. Nostrum Biodiscovery’s customer-tailored solutions are based on state-of-the-art proprietary and 3rd-party software, combined with the latest development on AI. We use best in-class Molecular Modeling for data augmentation and fine-tuning of dedicated machine-learning algorithms. With … Type: | 13 | 0 | 7 | 41 |
 | Quality Electrodynamics (QED) Engineering Healthcare Innovations Quality Electrodynamics (QED) is a global developer, manufacturer and supplier of advanced medical equipment electronics. Current products include cutting edge MRI radiofrequency (RF) antennas/coils for diagnostic imaging at the full range of magnetic field strengths. Most of these are FDA Class II noninvasive devices used for obtaining diagnostic images for various human anatomies. Advanced Manufacturing, Medical Device, Additive Manufacturing, and MRI RF coils Type: | 1 | 1 | 0 | 94 |
 | Future Port Spreading positive vibes through global tech events and impact awards empowering youth for a better future. Future Port's mission is to present a positive vision of the future, and empower people with a bold mindset, exponential technology, and courage to start building a better tomorrow for everyone, through exciting events and communities. Despite the many challenges world faces today and how it is portrayed by media, we are living in the most extraordinary times in human history. As humankind, we objectively live longer, healthier, richer, and happier lives than ever. More than that, nobody before us had such powerful tools … Type: | 9 | 1 | 4 | 20 |
 | PureTech Health Giving Life to Science PureTech is a clinical-stage biotherapeutics company dedicated to giving life to new classes of medicine to change the lives of patients with devastating diseases. The Company has created a broad and deep pipeline through its experienced research and development team and its extensive network of scientists, clinicians and industry leaders that is being advanced both internally and through its Founded Entities. PureTech's R&D engine has resulted in the development of 29 therapeutics and therapeutic candidates, including two that have received both U.S. FDA clearance and European marketing authorization and a third (KarXT) that has been filed … Type: | 15 | 1 | 8 | 106 |
 | PharmEnable Therapeutics Harnessing the power of chemical novelty, diversity and 3-dimensionality to develop innovative small molecule drugs PharmEnable is a biopharmaceutical company utilizing AI to discover effective small-molecule medicines for disease targets that are inaccessible to antibodies. With our proprietary AI-enabled drug discovery platform, chemSEEK, we explore new chemical spaces and discover novel small molecules with antibody-like specificity and selectivity. We are developing a pipeline of wholly owned therapeutics with initial focus on oncology and neurology. We also engage in drug discovery partnerships across a range of disease areas where accessing the target poses a significant challenge. PharmEnable is based in Cambridge, … Type: | 6 | 1 | 5 | 21 |
 | Hulptroepen Alliantie [Automatic translation follows] The Emergency Response Alliance supplies personal protective equipment, rapid tests and antibody tests to healthcare organizations, companies and consumers. Type: | 1 | 1 | 0 | 3 |
 | Röchling Medical Medical plastics solutions for every patient, everywhere, every day As a family-owned business, we empower our customers with innovative products and services to enhance patient health and save lives globally. This is the mission of Röchling Medical. With deep expertise in cleanroom plastics processing, we operate globally at six sites in Europe, the USA, and Asia. Our focus is on developing innovative, customized solutions for the healthcare industry, making us a trusted partner to leading pharmaceutical, biotech, and medical device companies. We specialize in designing and manufacturing customized pharmaceutical packaging, advanced drug delivery systems, and sophisticated components for medical devices. … Type: | 0 | 0 | 0 | 286 |
 | Anavex Life Sciences Anavex utilizes genomic biomarkers in precision medicine to treat severe neurological disorders Anavex Life Sciences Corp. (Nasdaq: AVXL) is a publicly traded biopharmaceutical company dedicated to the development of novel therapeutics for the treatment of neurodegenerative and neurodevelopmental disorders, including Alzheimer's disease, Parkinson's disease, Rett syndrome, schizophrenia and other central nervous system (CNS) diseases, pain, and various types of cancer. Anavex's lead drug candidate, ANAVEX®2-73 (blarcamesine), has successfully completed a Phase 2a and a Phase 2b/3 clinical trial for Alzheimer's disease, a Phase 2 proof-of-concept study in Parkinson's disease dementia, and both a Phase 2 and a Phase 3 study … Type: | 1 | 0 | 1 | 50 |
 | Cernostics Providing Deeper Tissue Insights Cernostics has joined Castle Biosciences. Please stay connected! https://www.linkedin.com/company/castle-biosciences-inc-/ Cernostics is a diagnostics company focused on delivering next generation cancer diagnostics and prognostics through a unique approach to tissue analysis. Most current diagnostic approaches offer a limited view of cancer because they fail to evaluate the tumor as a system composed of multiple interacting cell types. Cernostics takes a tissue systems biology approach to anatomic pathology. Its patent-protected technology platform, TissueCypher, uniquely analyzes whole slide digital images with multiplexed fluorescence, providing greater information and accuracy than traditional subjective tissue diagnostics. Learn more about our technology platform … Type: | 0 | 0 | 0 | 557 |
 | Rahko Part of Odyssey Therapeutics Rahko was acquired by Odyssey Therapeutics in 2021. Odyssey Therapeutics is a biotech company pioneering next gen immunomodulators and oncology medicine. Read more: https://odysseytx.com/news/ Type: | 5 | 0 | 3 | 1 |
 | Milestone Pharmaceuticals, Inc. Headquartered in Montreal, with a growing subsidiary in Charlotte, NC Thank you for your interest in Milestone Pharmaceuticals. While we encourage you to explore opportunities with our company, we urge you to be cautious and wary of recruitment scams in which fraudsters pose as representatives of Milestone Pharma. All current openings are available to view on our Careers page. https://milestonepharmaceuticals.applytojob.com/ Milestone Pharmaceuticals Inc. (Nasdaq: MIST) is a Phase 3 clinical-stage biopharmaceutical company dedicated to developing and commercializing the investigational new drug etripamil for the treatment of cardiovascular indications. Etripamil is a novel, potent and short-acting calcium channel blocker designed by … Type: | 1 | 1 | 1 | 45 |
 | Sirona Biochem Corp. Advancing chemistry. Enhancing health. Sirona Biochem is a cosmetic ingredient and drug discovery company with a proprietary platform technology. Sirona specializes in stabilizing carbohydrate molecules with the goal of improving efficacy and safety. New compounds are patented for maximum revenue potential. Sirona’s compounds are licensed to leading companies around the world in return for licensing fees, milestone fees and ongoing royalty payments. Sirona’s laboratory, TFChem (located in France) is the recipient of multiple French scientific awards and European Union and French government grants. Sirona Biochem is a publicly-traded company. The company is listed on the TSX Venture Exchange in Canada … Type: | 5 | 0 | 4 | 5 |
 | Ampans [Automatic translation follows] Commitment to people with intellectual disabilities AMPANS is a foundation that works to promote the education, quality of life and employment of people with intellectual disabilities, managing centers, services, programs and supports with criteria of accredited excellence. Ampans is a foundation, with 50 years of history, committed to people with intellectual disabilities and their families. We accompany and support more than 1,500 people and their families by offering continuous, flexible, adapted and close care services. The range of AMPANS services embraces all ages and adapts to all degrees of dependency. The aim of our service is to … Type: | 11 | 1 | 8 | 326 |
 | Walk With Path Limited Enhancing human life and shaping the future world by creating inclusive innovations to make a positive impact. 🏔 Explore beyond possible. 🦿 Enhancing human life and shaping the future world by creating inclusive innovations to make a positive impact. Product design, Medical devices, Innovation design engineering, Innovation, Parkinson's, Diabetes, Gait disorders, Data science, and Remote monitoring Type: | 16 | 6 | 12 | 14 |
 | Spindiag GmbH The infection control solution. Spindiag is a spin-off of Hahn-Schickard, one of the world’s leading research institutions for microsystems technology. Based on its patented microfluidic platform “LabDisk”, Spindiag develops an easy-to-use, compact, and automated point-of-care system for the broad, fast, and affordable screening for respiratory pathogens such as SARS-CoV-2 or drug-resistant pathogens. Behavior guidelines: https://www.spindiag.de/social-media-netiquette/ Impressum Spindiag GmbH Daniel Mark Engesserstr. 4a 79108 Freiburg Germany Email: info@spindiag.de Phone: +49 761 203 73246 Amtsgericht Freiburg im Breisgau HRB 714527 Tax ID number: DE305897842 point-of-care testing and in-vitro diagnostics Type: | 3 | 0 | 3 | 8 |
 | Laverock Therapeutics Programmable gene silencing to transform advanced therapies Next generation programmable cell therapies Type: | 2 | 0 | 2 | 37 |
 | Transimmune AG Restoring immune surveillance through natural immunity - a revolution in dendritic cell therapy. Transimmune AG is leading a revolution in dendritic cell therapy having uncovered how dendritic cells are made physiologically in vivo. Type: | 0 | 0 | 0 | 3 |
 | ANGANY Immunity Humanité ANGANY is an emerging, private pharmaceutical company, based in Quebec City, Canada. ANGANY has tackled the specific challenges of allergy to invent first-in class pharmaceuticals. ANGANY has developed an exclusive vaccine platform based on synthetic biology: the eBioparticle TM self-adjuvant vector. ANGANY also produces high quality, high purity allergens for diagnostic purposes. Finally, ANGANY has developed a flexible, fast and highly scalable 3rd generation plant production platform. ANGANY's vaccine approach opens the door to applications in cancer, infectious, autoimmune diseases and others. ANGANY is a Franco-Canadian collaboration led by Louis-Philippe Vézina, a renowned pharmaceutical entrepreneur. allergenes recombinants, immunotherapy, … Type: | 0 | 0 | 0 | 20 |
 | APTEEUS Reconcile the time of Research with the one of Medecine APTEΞUS was created to provide clinicians and their patients suffering from orphan diseases, an innovative service of clinical biology that perfectly meets the emerging challenge of individualized medicine. APTEΞUS is engaged in patient-centric discovery of individualized treatments. Our technology allows the testing of thousands of molecules directly on primary cells sampled from patient with inborn error of metabolism. We can rapidly identify molecules that specifically correct the very molecular defect of the patient and give him a new opportunity to be cured. Type: | 0 | 0 | 0 | 8 |
 | Entero Therapeutics (Nasdaq: ENTO) A biopharma company focused on the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases Entero Therapeutics, Inc., is a late clinical-stage biopharmaceutical company focused on the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases. The Company’s programs address significant unmet needs in GI health and include: latiglutenase, a Phase 3-ready, potentially first-in-class, targeted, oral biotherapeutic for celiac disease; capeserod, a selective 5-HT4 receptor partial agonist for indications including gastroparesis; and adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients in cystic fibrosis and chronic pancreatitis patients with exocrine pancreatic insufficiency. For more … Type: | 2 | 0 | 2 | 13 |
 | Neurolixis New treatments for central nervous system disorders Neurolixis Inc. is a biopharmaceutical company focused on the discovery and development of novel drugs for the treatment of human central nervous system diseases including movement disorders, autism spectrum disorders, depression and pain. Neuroscience, Drug development, Rett Syndrome, Parkinson's disease, Biased agonism, and Orphan Drug Type: | 2 | 1 | 1 | 6 |
 | Adverum Biotechnologies We are on a global mission to establish gene therapy as a new standard of care for the leading causes of vision loss. Adverum Biotechnologies (NASDAQ: ADVM) is a clinical-stage company that aims to establish gene therapy as a new standard of care for highly prevalent ocular diseases with the aspiration of developing functional cures to restore vision and prevent blindness. Leveraging the research capabilities of its proprietary, intravitreal (IVT) platform, Adverum is developing durable, single-administration therapies, designed to be delivered in physicians’ offices, to eliminate the need for frequent ocular injections to treat these diseases. Adverum is evaluating its … Type: | 0 | 0 | 0 | 157 |
 | ZEDIRA GmbH Targeting Transglutaminase for Research & Medicine! ZED1227 First Tissue Transglutaminase Inhibitor in Clinical Trials! Zedira is specialist and global brand for transglutaminase. More than 200 specialty reagents for transglutaminase-related R&D. Researchers from academia and industry (including 12 of the top 15 big pharma companies) benefit from Zedira’s cutting edge products – and in an increasing manner – from customised services. Solutions for site specific labeling of proteins using transglutaminases form Zedira’s latest product field. Simply - "The Transglutaminase Company" and From bench to bedside Type: | 1 | 1 | 0 | 11 |
 | OakLabs Scientific Reach New Heights With Your Biomarkers At OakLabs Scientific, we believe that each of us can live longer healthy. In a society where individual healthcare is increasingly challenging, we are pioneering ways to detect and avert disease before it occurs. Using our unique Artificial Intelligence algorithms and high-molecular-weight data, we are exploring individual health status in unprecedented depth. gene expression analysis, biotechnology, research, biomarkers, biomarker signatures, and companion diagnostics Type: | 1 | 1 | 0 | 6 |
 | ChromoTek new tools for better research #newtoolsforbetterresearch Part of Proteintech Group. ChromoTek pioneered the development and commercialization of alpaca Nanobodies. As a market and product leader for high quality and reliable Nanobody-based reagents, we assist scientists’ research world-wide. In addition, ChromoTek is a trusted service provider of custom-made Nanobodies for the pharmaceutical industry. Founded in 2008 ChromoTek has offices in Martinsried, Germany, and Hauppauge, NY. In contrast to traditional antibodies Nanobodies consist of only one single polypeptide chain; they are 15 kDa and the smallest antibodies known. ChromoTek GmbH, Affinity purification, Immunoprecipitation, Co-IP, Mass spectrometry, Ligand capture, Protein-protein interaction, GFP-Trap, Fluorescent … Type: | 2 | 1 | 1 | 17 |
 | Easy Medical Device Consulting Agency. Help you place your Compliant Medical Device on the market Easy Medical Device is a company that will support you to place your Medical Device on the market. With its network, the company is capable of finding you the right support you need to execute your tasks. If you have a project to develop or a problem to solve in terms of Quality and Regulatory Affairs, Easy Medical Device is your solution. We help companies that are bringing new devices on the market or companies that just need an upgrade of their system. We can also find you … Type: | 0 | 0 | 0 | 11 |
 | VectorBuilder VectorBuilder is a global leader in gene delivery technologies. As a trusted partner for thousands of labs and biotech/pharma companies across the globe, VectorBuilder offers a full spectrum of gene delivery solutions covering virtually all research and clinical needs from bench to bedside. VectorBuilder is the future of gene delivery. Our mission is to provide end-to-end solutions for all gene delivery needs spanning both research and therapy. We strive to offer innovative and high-quality products and services while maintaining rapid turnaround and exceptional affordability. Our “white-glove” customer care is supported by a PhD-level team with decades of collective experience to … Type: | 10 | 1 | 8 | 79 |
 | DBS System Making blood samples travel - not people. DBS System is a medtech company located in the Swiss Health Valley providing advanced technology to collect and prepare blood samples in a less invasive, easier, cheaper, safer manner with precision and industry standard processes. We produce devices with patent pending microfluidic technology capable of plasma/serum extraction and volume control in a standardized and reliable format, dramatically increasing the potential of DBS samples in bioanalysis. The innovative HemaXis platform was developed to combine the power of labs to test and monitor health with people’s desire to stay well. HemaXis will help democratize blood … Type: | 2 | 0 | 2 | 6 |
 | Kiyatec Inc. Changing the future of cancer care by accurately predicting patient response to therapies before treatment begins Kiyatec is disrupting cancer care by accurately predicting patient–specific response and non–response before treatment begins. We utilize the patient’s own living tumor cells to create functional 3D models to test a battery of cancer therapies in our CLIA-certified and research laboratories. Our goal is to enable physicians to isolate only the effective treatments for their patients as quickly as possible - making true personalized medicine a reality. Our approach has been validated through engagements with leading cancer hospitals, multiple top 10 pharmaceutical companies and … Type: | 1 | 0 | 1 | 21 |
 | Q-linea At Q-linea, we design, develop, and deliver innovative technology to aid physicians and technicians to improve patient outcomes and save lives. We aim to vastly reduce the time to optimal therapy. Q-linea provides infectious disease diagnostics to create sustainable healthcare, now and in the future. For patients, physicians, and society. The company’s leading product, ASTar®, is a fully automated instrument for antimicrobial susceptibility testing, which produces a sensitivity profile from a positive blood culture within approximately six hours. This is 24 to 40 hours faster than current diagnostics. This contributes to reducing the use of broad-spectrum antibiotics. ASTar is CE-IVD … Type: | 0 | 0 | 0 | 94 |
 | Seres Therapeutics Leading the Microbiome revolution Seres Therapeutics is a commercial-stage company developing novel microbiome therapeutics for serious diseases. Our lead program, VOWSTTM, obtained U.S. FDA approval in April 2023 as the first orally administered microbiota-based therapeutic to prevent recurrence of C. difficile infection (CDI) in adults following antibacterial treatment for recurrent CDI and is being commercialized in collaboration with Nestlé Health Science. We are evaluating SER-155 in a Phase 1b study in patients receiving allogeneic hematopoietic stem cell transplantation to reduce incidences of gastrointestinal infections, bloodstream infections, and graft-versus-host disease as well as additional preclinical stage programs targeting Infection Protection in … Type: | 3 | 1 | 1 | 275 |
 | MRM Health Redefining microbiome-based therapeutics MRM Health NV is a biopharmaceutical company focused on the discovery and development of innovative therapeutics based on the human microbiome.The company is based in a Center of Expertise for microbiome research and development in the biotech cluster in Ghent, Belgium, and has a strategic partnership with the VIB, with top research groups in both microbiome analysis and ecology and in host biology and disease research. The Company is strategically supported by strong local and international investors, including Ackermans & van Haaren, DuPont, MRM Technologies, Qbic II and VIB and has a corporate collaboration with DuPont Nutrition … Type: | 1 | 1 | 0 | 43 |
 | MV BioTherapeutics SA A Microbiota biotherapeutics and Vaccines company. Conditioning the gut ecosystem for disease prevention and therapy. Spin-off from the Institute for Research in Biomedicine (IRB) in Bellinzona, Switzerland, aimed at shaping the intestinal microbiota for the cure and prevention of diseases such as bowel diseases and cancer. The gut ecosystem conditions the function of all our organs and plays a fundamental role in our wellbeing. The mucosal immune system has co-evolved with the intestinal microbiota to adapt its function to a number of environmental and possibly pathogenic factors. MV Bio leverages a microbiota-mediated mechanism regulating the physiological response of the intestinal … Type: | 1 | 1 | 0 | 1 |
 | OPPILOTECH LTD Navigating Biology, Discovering Drugs Oppilotech have developed a high-resolution platform based on systems biology and machine learning to model biological processes in cells. We use the models to simulate biological processes in order to identify viable drug targets and discover new biology. The company is building a pipeline of first-in-class drug discovery programmes based on the identified targets. Type: | 1 | 1 | 0 | 10 |
 | PEPperPRINT GmbH The leading provider of high-density peptide microarrays for antibody validation, epitope mapping & antigen discovery. PEPperPRINT is an innovative biotech company from Heidelberg, Germany, and the leading provider of high density peptide and protein microarrays for antibody characterization or the fingerprint analysis of antibody responses from biological samples. The product and service portfolio was recently complemented by T cell epitope mapping and monitoring, making PEPperPRINT a one-stop solution provider for the fingerprint analysis of immune responses e.g. for epitope mapping, antibody biomarker discovery or the analysis of adverse immune effects. PEPperPRINT’s peptide microarrays and screening services have been used by … Type: | 1 | 1 | 0 | 24 |
 | GQ Bio Therapeutics High-Capacity Gene Therapy Vector Platform to Address Prevalent Diseases GQ Bio is pioneering a high-capacity gene therapy vector platform (HCAd) that addresses some of the big challenges in the gene therapy field: Transfer of large and multiple genes with a single vector, highly efficient gene delivery (high transduction efficiency), and large-scale manufacturability. Based on its HCAd vector platform, GQ Bio develops transformative treatments for chronic, prevalent conditions such as osteoarthritis and intervertebral disc degeneration. GQ Bio is headquartered in Hamburg, Germany and has sites at Luckenwalde (greater Berlin area), Germany and Liège, Belgium. biotechnology, gene therapy, osteoarthritis, drug development, human … Type: | 3 | 2 | 0 | 17 |
 | LDMH Partners Life Sciences Advisors. UK | EU | North America We are a niche life sciences advisory firm, and a full service law firm, with exceptional expertise in human tissue- and cell-based research, clinical care, and assisted reproduction. We advise established biotechnology companies as well as start-ups, fertility clinics, and biobanks. medical ethics, data protection, medical law, autonomy, biotechnology, clinical trials, consent, GDPR, Law, and Life sciences law Type: | 0 | 0 | 0 | 7 |
 | siTOOLs Biotech GmbH High Specificity Tools for RNAi, rRNA depletion & RNA Interactome Studies. Services: Making Sense of RNAi Screening Data We drive RNA research with tailored molecular tools. We are from Munich and provide researchers with highly complex & advanced genetic tools. Our core expertise is RNA interference, bioinformatics, and RNA research tools for RNA-Seq and Ribo-Seq. Distinguished by their exceptional targeting specificity and efficiency, our gene function analysis tools include - siPOOLTM for reliable gene silencing, raPOOLTM for targeted RNA affinity purification and riboPOOLTM for efficient ribosomal RNA depletion. Our technology combines high complexity oligo pooling (“Pack Hunter” approach), proprietary design … Type: | 1 | 0 | 1 | 11 |
 | Mindi Independent Health Curator Guiding regular people into Curated Independent Healthcare, giving exclusive access to uncensored content, the very best independent medical professionals, and the most advanced treatments with no wait and extreme privacy. Telehealth, Advanced Therapeutics, Medical Content, Prescriptions, Exclusive Clinic Access, Women's Health, Men's Health, and COVID-19 Type: | 0 | 0 | 0 | 10 |
 | Landmark BioVentures AG Integrated and agile biotech hub-and-spoke company Landmark BioVentures AG (LBV), founded in 2021 and headquartered in Basel, Switzerland, is an integrated and agile biotech hub-and-spoke company. LBV takes a unique model focused on lean operations, smart capital allocation, and diversified yet complementary nexus of seven companies developing 10 first in class therapeutics. drug development , biotech, oncology, immuno-oncology, ophthalmology, immunology, pathobiology, inflammation, and business development Type: | 5 | 1 | 5 | 4 |
 | Neurentis plc NEW FRONTIERS IN NEUROSCIENCE Expertise, Experience, Innovation, Vision, Values. Neurentis PLC is a late-clinical stage UK biotech company, focusing on neuroscience and specialising in the development of novel treatments for mental health and other neurological and psychiatric diseases. Our product pipeline is balanced with 3 products: 1) an advanced lead drug candidate, a prescription pharmaceutical (selegiline), in a transdermal patch, for the treatment of Treatment-Resistant Depression (TRD) in the last stages of drug development, 2) a small molecule agonist of the oxytocin receptors for the treatment of Autism, Chronic and Neuropathic Pain and addiction to alcohol and opioids and 3) … Type: | 1 | 1 | 0 | 3 |
 | ZEBRA MEDICAL Care without compromise. We go beyond the conventional role of providing medical devices. Medical device manufacturer and distributor of specialised products mainly in the fields of oncology, pain management, ultrasound and cellAED Type: | 0 | 0 | 0 | 13 |
 | IceCure Medical The Choice of Cryoablation IceCure Medical is a medical device company dedicated to providing patients and healthcare providers with the minimally invasive choice of cryoablation using liquid nitrogen for the treatment of benign and cancerous tumors. Our flagship device, the ProSense System, utilizes the power of liquid nitrogen to generate ultra-cold temperatures quickly to create large lethal zones that freeze and destroy tumors. By using liquid nitrogen, the system enables procedures to be performed in office-based settings, as there is no need for special safety precautions compared to other high-pressure gases used in cryoablation such as argon. In 2024, IceCure … Type: | 0 | 0 | 0 | 71 |
 | ObsEva SA ObsEva. Nature meets Nurture Innovating Women’s Reproductive Health and Pregnancy Therapeutics ObsEva is a clinical-stage biopharmaceutical company focused on the clinical development and commercialization of novel therapeutics for serious conditions that compromise a woman's reproductive health and pregnancy. For more information, please visit www.ObsEva.com. Type: | 0 | 0 | 0 | 11 |
 | Silence Therapeutics plc Precision Engineered Medicines to Silence Diseases Our 20-plus years of RNAi experience together with our validated mRNAi GOLDTM platform make us a partner of choice for pharmaceutical companies looking to access the benefits of the siRNA and add this revolutionary modality to their discovery pipeline. As pioneers in the design and development of siRNAs (short interfering RNAs), Silence Therapeutics is advancing a new generation of medicines to potentially address the needs of patients who have limited or inadequate treatment options. Our mission is to use our technology to create a new generation of therapeutics which can improve outcomes for patients … Type: | 0 | 0 | 0 | 108 |
 | BioNTech IMFS BioNTech Innovative Manufacturing Services (IMFS) is a subsidary of BioNTech SE. We are specialized in the development and production of innovative products (viral vectors, cells and ivt mRNA). Based on extensive expertise in scientific, technical and regulatory prerequisites, we develop and manufacture your products in a safe and cost-efficient way in our state-of-the-art GMP facilities. We offer contract services for retroviral vector manufacturing for clinical supply. The company has more than 500 experienced and highly skilled employees and is always looking for motivated people! See also www.biontech-imfs.de Cell therapy, GMP manufacturing, Gene Therapy, RNA manufacturing, Retroviral vector manufacturing, Contract Manufacturing, … Type: | 0 | 0 | 0 | 251 |
 | Alzforum Alzforum, founded in 1996, is a free, dynamic, web-based scientific community dedicated to understanding Alzheimer's disease and related disorders. Our editorial priorities are as diverse as the needs of the research community. The website reports news on the latest scientific findings from basic research to clinical trials; maintains public databases of animal models, therapeutics, genetic risk factors, and biomarkers; and holds live discussion forums to promote debate, speed the dissemination of new ideas, and break down barriers across the numerous disciplines that can contribute to the global effort to cure Alzheimer's disease. The Alzforum team of professional science writers and … Type: | 0 | 0 | 0 | 11 |
 | Seelos Therapeutics, Inc. A clinical-stage biopharmaceutical company focused on central nervous system disorders and rare diseases. Seelos Therapeutics, Inc. is a clinical-stage bio-pharmaceutical company focused on the development and advancement of novel therapeutics to address unmet medical needs for the benefit of patients with central nervous system (CNS) disorders and in rare diseases. The Company’s portfolio includes several late-stage clinical assets targeting psychiatric and movement disorders, including orphan diseases. Seelos is based in New York, New York. Seelos’ common stock is traded on The Nasdaq Capital Market under the symbol "SEEL". Rare Diseases, Parkinson's Disease, Sanfilippo Syndrome, Suicidality, Depression, PTSD, MDD, CNS Disorders, … Type: | 2 | 0 | 1 | 12 |
 | Cerule International Building Extraordinary Lives® with proven, cutting-edge dietary supplements and skin care products. Cerule® is a biotech company that sells proven, one of a kind dietary supplements, skin care and wellness products. Our products are validated by years of scientific research and development, patents and published scientific papers. We challenge the status quo and are constantly striving to find and develop groundbreaking health solutions that produce positive changes to help you live a longer, healthier and happier life. It is with this mission that Cerule has been positively impacting countless lives worldwide for more than a decade. We believe the extraordinary … Type: | 0 | 0 | 0 | 114 |
 | BIOSENIC S.A. New solutions for autoimmune, inflammatory and bone diseases. BioSenic is an innovative company with the objective of addressing important unmet medical needs in the areas of immunity, auto-immune diseases and organ repair. Cell therapy, Bone and joint tissue regeneration, Osteo-Articular Diseases, autoimmunity, immunity, autoimmune disease, and arsenic Type: | 16 | 4 | 11 | 26 |
 | ITM Isotope Technologies Munich SE Dedicated to giving cancer patients better answers than "maybe". PASSION FOR PRECISION. ITM Isotope Technologies Munich SE is a privately owned biotechnology and radiopharmaceutical group of companies dedicated to the development, production and global supply of targeted diagnostic and therapeutic radiopharmaceuticals and radioisotopes for use in cancer treatment. Since its foundation in 2004, ITM and its subsidiaries have established GMP manufacturing and a robust global supply network of a novel, first-in-class medical radioisotopes and generator platform for a new generation of targeted cancer diagnostics and therapies. Furthermore, ITM is developing a proprietary portfolio and growing pipeline of targeted treatments in … Type: | 1 | 0 | 1 | 445 |
 | ADDvise Group AB (publ) Leading supplier of equipment to healthcare and research facilities ADDvise is a leading supplier of equipment to healthcare and research facilities. ADDvise Group AB (publ) is an expanding group that offers total solutions in products and services to healthcare and research facilities through its subsidiaries. We develop and nurtures long-term relationships by offering leading edge competence in our two business units Lab and Healthcare. Our subsidiaries are divided equal into the business fields. Lab creates modern research facilities by providing laboratory furnishings, safety ventilation, climate rooms, clean rooms and laboratory apparatus to e.g. the pharmaceuticals industry and life science research. … Type: | 0 | 0 | 0 | 30 |
 | Protembis GmbH Full Cerebral Embolic Protection System to Reduce the Risk of Cerebrovascular Events during TAVR/ TAVI. Protembis is an Aachen, Germany based medical device startup. It develops a novel catheter-based filter device for use during cardiac interventions. The device is designed to minimize the risk of stroke and other neurological injury during these interventions – particularly during transcatheter aortic valve replacement procedures (TAVR/ TAVI). The filter blocks embolic debris from entering the blood vessels leading to the brain. The initial safety and feasibility of the ProtEmbo® device has been demonstrated in a first-in-human study in 2017/ 2018. The imaging data of … Type: | 0 | 0 | 0 | 22 |
 | Memo Therapeutics AG Memo Therapeutics AG (“MTx”) is a late-stage biotech company translating unique human immune responses into superior medicines through the development of best-in-class antibodies to treat viral infections and cancer. The Company’s lead program, Potravitug, is in Phase II development targeting BK viremia (BKV) in kidney transplant recipients, an infection which can result in decreased kidney functionality and longevity and reduced patient survival. Potravitug has the potential to become the best and first-in-class BKV disease-modifying therapy for kidney transplant patients. Alongside Potravitug, MTx is focused on discovering novel antibody-target pairs for oncology based on tumor infiltrating B-cells derived leveraging tertiary lymphoid … Type: | 3 | 2 | 2 | 39 |
 | VarmX VarmX is a young biotech company focusing on the development of therapies in the field of hemostasis and thrombosis. VarmX (www.varmx.com) is a young Leiden based biotech company that is focusing on the development of therapies in the field of hemostasis and thrombosis. Originally a spin-off from the Leiden University Medical Center (LUMC), our mission is to develop and manufacture therapeutic proteins to restore hemostasis. Our lead compound, VMX-C001, is intended to safely and effectively restore hemostasis in case of bleeding or emergency surgery in patients taking so-called oral factor Xa inhibitors. The VarmX program has gained significant interest in … Type: | 0 | 0 | 0 | 26 |
 | Acousia Therapeutics GmbH Enhance & Preserve Natural Hearing ! Acousia is a pioneer of novel medicines. Founded in 2012, the company’s experienced and entrepreneurial management team is committed to combating hearing loss. Thanks to its exclusive collaboration agreement with the renowned Translational Hearing Research Group of Tuebingen University Clinic and an ecosystem of experts and CROs, Acousia has made significant strides with its advanced small molecule drug candidates. Hearing Loss Treatment and Hearing Loss Drug Development Type: | 1 | 0 | 0 | 5 |
 | Manina Medtech Boosting In Vitro Fertilisation Success Infertility is a global health problem, with a rising incidence, affecting one in every six couples and 190 million people worldwide. In Vitro Fertilisation (IVF), one of the most known infertility treatments, has gained awareness and clients. However, of the nearly a million IVF cycles done in Europe annually, only 40% result in pregnancy. Low IVF success makes the process long, expensive, and emotionally devastating. Manina Medtech is a young startup with a B2B business model and the vision that every woman who goes through IVF requires a single IVF cycle to get pregnant. We … Type: | 1 | 0 | 0 | 6 |
 | Qorium Real Leather, Reinvented Leather is loved. Leather is luxury. Leather is everywhere. Unfortunately, making leather is also polluting, challenging and controversial. Qorium creates beautiful, premium, and authentic leather without compromise. Cutting-edge science empowers us to dramatically reduce the vast impacts of today’s leather industry without quality reductions. By removing the cow from leather production, Qorium’s material has minimal climate impacts, low water and chemical usage, no land use, and no animal impacts. Simply put, Qorium reinvents leather. Better product. Better planet. Biotechnology, Cell cultured leather, Leather, Cell grown Leather, Sustainable Leather, and Animal free Leather Type: | 1 | 0 | 1 | 19 |
 | MolDrug Chemoinformatics and modeling solutions to optimize your drug candidates. MolDrug (a ProtoQSAR company) is a group specializing in the design and optimization of molecules through Machine Learning-powered chemoinformatics and structural bioinformatics. Our models allow for the prediction of molecular properties (QSAR) and detailed interaction analyses (molecular modelling). We work with all types of compounds, including small molecules, peptides, nanomaterials, mixtures... Our tools allow for the prediction and assessment of physicochemical, biological, pharmacological, and/or (eco)toxicological properties of substances with an array of advantages: - faster results - saving money and resources - reduce animal testing (3 Rs) - regulatory validity (REACH, … Type: | 0 | 0 | 0 | 3 |
 | Relation Discovering the relationships at the heart of biology to cure disease. We are an end-to-end biotech developing transformational medicines, with technology at our core. Our ambition is to understand human biology in an unprecedented way; discovering therapies that will treat some of life's most devastating diseases. We leverage single-cell and multi-omics measurements directly from patient tissue, functional assays and machine learning to drive disease understanding — from cause to cure. Medicines born from high-resolution biology, machine learning and clinical insights. Our Lab-in-the-Loop seamlessly integrates single-cell analysis, genomics and machine learning. We have developed powerful technologies which we apply to select … Type: | 11 | 0 | 9 | 73 |
 | CYTENA We make the development of modern therapies faster, safer, and more affordable. Join us to create the future of health! We at CYTENA strive to empower our customers to serve patients faster and better. To accelerate workflows and bring new insights into biotherapeutic drug development, we provide precise control of individual cells through automation and microtechnology. Our instruments offer automated isolation of single cells with assurance of clonality and selection based on cell morphology. We can isolate many common cell types including bacteria. Our high viability rates make our instruments compatible with cell line development, single cell analysis, and other … Type: | 1 | 1 | 0 | 72 |
 | Circuit Clinical An IRO committed to better access to clinical research, the development of new medicines, and health equity. Circuit Clinical, one of the fastest-growing research networks in the USA, is dedicated to empowering patients to choose clinical research as a care option through improved access to clinical trials. Committed to transforming the experience of finding, choosing, and participating in clinical research for physicians and their patients, Circuit provides clinical research services through traditional, hybrid, and decentralized community-based site models and their MD Prescreen service that optimizes patient referrals. Learn more at circuitclinical.com Clinical Research Enrollment Solutions, Patient Recruiting Services, Clinical Site … Type: | 10 | 1 | 6 | 101 |
 | Menten AI Building the world's most advanced generative AI platform for peptide therapeutics design. Menten AI is a drug discovery company focused on designing peptides for conditions with high unmet medical need. We are developing the world's most advanced generative AI platform for peptide therapeutics. Type: | 9 | 1 | 6 | 14 |
 | HP Health Solutions Germany GmbH For more information, please visit www.gna-bio.com Laser PCR, Molecular Diagnostics, OEM, Molecular Technology, Biosecurity, Life Sciences, Food Safety, Nucleic Acid Amplification, Molecular Assays, Biotechnology, and Nanotechnology Type: | 1 | 0 | 0 | 28 |
 | IFPMA We represent the biopharmaceutical industry, partnering for global health progress and access to innovation. IFPMA represents the research-based pharmaceutical companies and associations across the globe. The research-based pharmaceutical industry’s 2 million employees research, develop and provide medicines and vaccines that improve the life of patients worldwide. Based in Geneva, IFPMA has official relations with the United Nations and contributes industry expertise to help the global health community find solutions that improve global health. Biopharmaceuticals, Global Health Policy, Health Advocacy, Innovation, Medicines Quality, and Multistakholder Collaboration Type: | 41 | 16 | 33 | 70 |
 | PB&B Facial & Body Remodeling Technology for Medical Aesthetics PB&B Ltd. is a specialty Swiss Life Sciences company founded by bioengineers working with plastic surgeons & dermatologists to test and bring to market a new patented injectable technology for the remodeling of soft tissues of the face & body. PBB-002 enhances adipocytes' volume with fatty acids, as to provide natural & longer-term results with the highest level of safety. PB&B’s patented technology aims to transform a fast growing, multi-billion-dollar facial aging & body remodeling markets with the next generation of injectables in Medical Aesthetics. Aesthetics, Facial rejuvenation, Breast augmentation, Buttock augmentation, … Type: | 0 | 0 | 0 | 4 |
 | Piomic Medical Advanced wound care, made personal. There are about 50 million reported cases of patients suffering from hard-to-heal wounds, which has created a severe cost burden on global healthcare systems. Piomic developed an innovative medical device for the treatment of hard-to-heal wounds. The COMS® One Therapy System is a portable, hand-held device that incorporates the technologies for optical and magnetic stimulation, intended to promote wound healing in chronic leg and foot ulcers. It integrates smoothly into the patient’s healing journey with usage in all care environments. By developing a therapy that is safe and effective we hope to set a better … Type: | 1 | 0 | 0 | 16 |
 | Cocoon Bioscience Proteins For Sustainability Cocoon Bioscience specializes in the manufacturing of high performance growth factors and enzymes using an automated platform leveraging cocooned insects as natural, low cost bioreactors. Type: | 2 | 1 | 1 | 29 |
 | Lymphatica Medtech Lymph Flow Matters Lymphatica develops medical devices for treatment of lymphatic diseases. Born in 2017 as a spin-off of 2 leading Swiss universities, our first product is intended to bring a terrific improvement in quality of life for lymphedema patients: LymphoDrain, the first implantable artificial lymphatic vessels, is a medical device intended to recirculate lymph inside the patient body, re-establishing the physiological fluid equilibrium. Type: | 4 | 3 | 1 | 12 |
 |  Aerogabs Aerogabs is a consulting service for Entrepreneurs and Small & Medium Business. We boost your Company Performance by designing a Culture of Innovation. We have over 15 years of experience with a strong expertise in high-tech industries such as aerospace and medical devices. We offer 3 solutions: 1-Singularity - understands the dynamic of your territory and then adapt your posture in order to maximize your customer benefits. 2-Strategy - leverages your customer benefits by fully exploiting your potential and reducing the competitive threats. 3-Adocacy - assists you in the implementation of your actionnable plan to boost your venture performance. Please … Type: | 0 | 0 | 0 | 1 |
 | Polyneuron Pharmaceuticals AG Precision treatment of immune disorders Polyneuron is a growing Basel-based biotechnology company active in the area of autoimmune disease treatments. The company was founded in 2014 as a spinout company from the University of Basel to develop novel treatments to combat immune disorders using its Antibody-CatchTM technology platform. The company currently employs about 10 people and has raised a significant amount in equity funding from top-tier VCs. We are a team of passionate and experienced scientists, entrepreneurs and investors willing to bring new therapies to patients. Type: | 2 | 1 | 0 | 4 |
 | Vicept Therapeutics, Inc Start-up Dermatology Company. Type: | 13 | 1 | 0 | 1 |
 | Quantgene We bring life-saving genomics to hospitals, physicians and patients everywhere. Quantgene decentralizes genomics to bring precision medicine to everyone. Our turnkey genomics platform empowers hospitals to move life-saving genomic diagnostics inside their organizations, unlock powerful new sources of revenue and become a driving force in clinical discovery. From complete genomic profiling to hereditary cancer testing and multi-cancer early detection, we help hospitals, physicians and patients to unlock the full power of precision genomics. Cancer diagnostics, biotechnology, genomics, machine learning, oncology, precision medicine, cancer screening, deep sequencing, cancer, innovation, AI, and Cancer Detection Type: | 4 | 0 | 4 | 39 |
 | VectivBio AG Life-Transforming Medicines for Patients Living with Serious Rare Diseases VectivBio AG is a clinical-stage biotechnology company focused on rare diseases with a well-defined biology that can be targeted with transformational therapeutics. VectivBio was formed in 2019 as a spinout from Therachon, a biotechnology company acquired by Pfizer, Inc., for its program in achondroplasia, with the ambition to continue to have an impact on people’s lives by bringing transformational medicines to patients with serious rare conditions. The company is led by a world-class leadership team with deep expertise in rare diseases and a track record of success in R&D, commercialization and … Type: | 2 | 0 | 1 | 57 |
 | eXmoor Pharma eXmoor is a full service Cell & Gene Therapy CDMO, backed by over 20 years manufacturing experience for 150+ clients eXmoor is a full service Cell & Gene Therapy CDMO with a difference. We are backed by 20 years consultancy experience supporting over 150 organisations accelerate novel therapies from discovery to patients. We provide expert solutions at all stages of the development journey from early process development and scale-up through to GMP manufacture, fill and finish and QP release. We are open, transparent and will work with you at every step to de-risk and streamline your project and maximise the … Type: | 1 | 0 | 1 | 78 |
 | OxyNov Revolutionizing oxygen therapy with the FreeO2: a device that optimizes every stage of treatment during hospital care. We are and want to remain pioneers in offering powerful, innovative, and cutting-edge technologies to oxygen therapy care. Our mission is to overcome the current limitations of respiratory care and oxygen therapy to : - Improve the safety and quality of life of patients. - Optimize care in a context of increasing number of patients and of hospitalization cost control. Our flagship device, the FreeO2, an automated oxygen therapy system : - Adjusts oxygen flow to the patient's needs in real time, avoiding … Type: | 3 | 1 | 1 | 15 |
 | Addex Therapeutics Allosteric modulators for Human Health Addex Therapeutics is a clinical-stage pharmaceutical company focused on the development and commercialization of an emerging class of novel orally available small molecule drugs known as allosteric modulators for neurological disorders. Allosteric modulators offer several potential advantages over conventional non-allosteric molecules and may offer an improved therapeutic approach to conventional "orthosteric" small molecule or biological drugs. Addex's allosteric modulator drug discovery platform targets receptors and other proteins that are recognized as essential for therapeutic intervention. Addex's lead drug candidate, dipraglurant (mGlu5 negative allosteric modulator or NAM), is poised to start a pivotal registration clinical trial … Type: | 3 | 0 | 3 | 18 |
 | Bioretec Ltd. better healing - better life Bioretec Ltd. is a medical device company focusing on the development of strong, safe and reliable bioabsorbable and bioresorbable implants for pediatric and adult orthopaedics. Our products are used worldwide, and we continue to further develop materials and products for load-bearing clinical applications. biomaterials, medical, manufacturing, medical devices, implants, absorbable metal, biopolymers, orthopaedics, and pediatric surgery Type: | 0 | 0 | 0 | 43 |
 | Novostia Heart valves for life, for patients of any age, including children Novostia is a privately held medical device company developing an innovative artificial heart valve, designed for patients of any age, including children. Novostia endeavors to advance its technology to clinical trials and regulatory approvals to improve the quality of life of millions of people worldwide suffering from aortic and mitral valve disease. For more information please visite www.novostia.com Heart Valves and Medical Devices Type: | 0 | 0 | 0 | 16 |
 | BÜHLMANN Laboratories AG BÜHLMANN is a fully independent, medium sized and family owned Swiss company. Founded in 1976, BÜHLMANN today has local teams in Switzerland, France, Italy, Germany, Austria, USA and Brazil and distributors worldwide. BÜHLMANN has become the prime calprotectin company within few years, offering the broadest range of calprotectin assays from fully automatable, high-throughput turbidimetric and ELISA assays, BÜHLMANN fCAL® turbo and BÜHLMANN fCAL® ELISA, to the point-of-care quantitative Quantum Blue® and IBDoc® home test application. Additional to calprotectin assays, BÜHLMANN offers therapeutic drug monitioring solutions for biologics used in chronic inflammatory diseases. BÜHLMANN does not only stand for calprotectin, but … Type: | 0 | 0 | 0 | 114 |
 | SeeO2 Energy Inc. Fuels and chemicals from CO2 SeeO2 Energy Inc. vision is to efficiently convert captured CO2 and/or water to fuels and chemicals using reversible solid oxide fuel cell technology. We provide our customers in the chemicals, metal processing, polymers, and utilities industries with a reliable, onsite and cost competitive industrial feedstocks for their products. ELECTROCHEMISTRY, Solid Oxide Fuel Cells, Solid Oxide Electrolysis Cells, Power to Gas, CO2 to Fuels, Reversible Fuel Cells, Electrolysers, Power to fuels, H2O electrolysis, CO2 electrolysis, and CO2 utilization Type: | 2 | 1 | 1 | 5 |
 | Diatech Pharmacogenetics Leader in the development, production and sales of pharmacogenetics tests for cancer precision medicine. Diatech Pharmacogenetics, the leading Italian Precision Medicine company. Diatech Pharmacogenetics is a provider of molecular diagnostic tools for precision medicine. The company aims at simplifying complex molecular diagnostic procedures into easy end-to-end solutions, from nucleic acids extraction and their molecular analysis, to final reporting. The company has 10 years of experience in the successful implementation of several nucleic acid analysis technologies into regulated diagnostic pipelines; examples include pyrosequencing, mass spectrometry and digital molecular barcoding. Leading cancer centres in Italy and abroad rely on Diatech CE-IVD solutions … Type: | 3 | 1 | 1 | 62 |
 | Sus Clinicals, Inc. Enabling our healthcare client partners to accelerate breakthrough cancer solutions. Sus Clinicals solves major problems in qualifying new cancer drugs, devices, diagnostics and therapies. Using a proprietary model of testing on genetically-modified pigs pioneered at the University of Illinois, Sus Clinicals leverages the inherent advantages of a patent-pending large animal testing methodology combined with novel clinical approaches to reduce false positives, model the interactions of multiple diseases, and accelerate progress toward human trials for the most promising therapies. Type: | 0 | 0 | 0 | 17 |
Startup